Inventor · disambiguated record
Laura E. Pope
Also filed as: POPE LAURA · POPE LAURA E
8 granted patents·11 pending applications·531 citations·filing 1994–2019
91Inventor score
Top patents by PatentIndex Score
19 records- 0196US7659282B2Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersAVANIR PHARMACEUTICALS INC·Filed 2005·Granted Feb 9, 2010·150 cites·12 claims
- 0295US8227484B2Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersYAKATAN GERALD·Filed 2012·Granted Jul 24, 2012·141 cites·17 claims
- 0392US5952392ALong-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibitionAVANIR PHARMACEUTICALS·Filed 1997·Granted Sep 14, 1999·144 cites·20 claims
- 0484US5534554ASucrose ester-C20 to C28 alcohol formulationsLIDAK PHARMACEUTICALS·Filed 1994·Granted Jul 9, 1996·54 cites·22 claims
- 0578US2020276185A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersAVANIR PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0677US2009082384A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersAVANIR PHARMACEUTICALS·Filed 2008·Application pending·0 cites
- 0775US7091190B2Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogsAVANIR PHARMACEUTICALS·Filed 2002·Granted Aug 15, 2006·7 cites·31 claims
- 0873US2014288114A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersAVANIR PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0973US2019201391A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersAVANIR PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1071US2014045880A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersAVANIR PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1170US2018098984A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersAVANIR PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1267US2016287576A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersAVANIR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1364US2015209347A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersAVANIR PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1463US2013072517A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersAVANIR PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 1557US5948822ATreatment of hyperproliferative skin disorders with C18 to C26 alphatic alcoholsLIDAK PHARMACEUTICALS·Filed 1997·Granted Sep 7, 1999·16 cites·7 claims
- 1656US2010137352A1Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disordersAVANIR PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 1754US6440980B1Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogsAVANIR PHARMACEUTICALS·Filed 1999·Granted Aug 27, 2002·10 cites·46 claims
- 1848US6313179B1Treatment of hyperproliferative skin disorders with C18 to C20 aliphatic alcoholsAVANIR PHARMACEUTICALS·Filed 1998·Granted Nov 6, 2001·9 cites·7 claims
- 1941US2004033982A1Viral inhibition by n-docosanolFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →